Nutri-Pharm (Aust) Pty Ltd is a pharmaceutical research company based in Melbourne, Australia
Trinsicore is a microencapsulation technology developed by Nutri-Pharm in association with the Medicines Manufacturing Innovation Centre (MMIC) at Monash University.
Established in 1999, Nutri-Pharm specialises in the therapeutics of natural compounds and the technologies which maximise those properties, whilst enhancing product safety.
Nutri-Pharm (Aust) Pty Ltd is an R&D company centered upon the development of novel carrier and delivery systems for the pharmaceutical, wound care, personal care and footwear industries. Products supported include natural anti-bacterial, anti-fungal, anti-inflammatory and wound healing compounds, along with essential oils, fragrances and pharmaceuticals.
Our aim is to build products with new technical capabilities for niche markets and new market segments.
We deliver natural active compounds more precisely and robustly, creating better, safer and more convenient products.
Nutri-Pharm's Vision and Values
Our Vision is to become the
innovation leader.
Over the past decade, Nutri-Pharm has re-aligned its priorities to address the global threat of microbial drug resistance.
Our purpose is to
respectfully serve the pharmaceutical, wound care, personal care and footwear markets with new technical capabilities for niche markets and new market segments.
Our mission is to create
sustainable, safer and more convenient products through the development of technical capabilities and novel carrier and delivery systems.
We strive for excellence and embrace the
diversity of all humanity.
Our values of innovation, respect, sustainability, excellence and diversity are embedded in our way of business.